6th Oligonucleotides for CNS Summit 2026
22 22 people viewed this event.
Oligonucleotide R and D is accelerating, driven by advances in brain shuttle technologies, RNA chemistry, and growing clinical validation from leaders such as Alnylam Pharmaceuticals, Stoke Therapeutics, and Ionis Pharmaceuticals. At the same time, major investments, including Novartis into Arrowhead Pharmaceuticals, Biogen into City Therapeutics, and Roche into Manifold Bio, underscore CNS as a key frontier for these technologies, unlocking previously undruggable targets.
Date and Time: Wednesday, 19 August 2026 at 08:00 – Friday, 21 August 2026 at 17:00
Venue details: The Colonnade Hotel, 120 Huntington Avenue, Boston, Massachusetts, 02116, United States
Prices:
USD 2299.00 – USD 4797.00
Event Organizer: Hanson Wade Conferences Ltd